Momenta Pharma (MNTA) Stock Price, Quote, News and Overview
NASDAQ:MNTA - Nasdaq -
MNTA Quote, Performance and Key Statistics
52.48
-0.01 (-0.02%)
The current stock price of MNTA is 52.48 null. In the past month the price increased by 0.63%. In the past year, price increased by 300.15%.
About MNTA
Company Profile
Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and its manufacturing process. They are applying their innovative technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.
Company Info
Momenta Pharma
301 BINNEY STREET
CAMBRIDGE MA 02142
CEO: Craig A. Wheeler
Phone: 617-491-9700
Momenta Pharma / MNTA FAQ
What is the stock price of Momenta Pharma today?
The current stock price of MNTA is 52.48 null. The price decreased by -0.02% in the last trading session.
What is the ticker symbol for Momenta Pharma stock?
The exchange symbol of Momenta Pharma is MNTA and it is listed on the Nasdaq exchange.
On which exchange is MNTA stock listed?
MNTA stock is listed on the Nasdaq exchange.
What is Momenta Pharma worth?
Momenta Pharma (MNTA) has a market capitalization of 6.25B null. This makes MNTA a Mid Cap stock.
What are the support and resistance levels for Momenta Pharma (MNTA) stock?
Momenta Pharma (MNTA) has a support level at 52.38 and a resistance level at 52.49. Check the full technical report for a detailed analysis of MNTA support and resistance levels.
Should I buy Momenta Pharma (MNTA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MNTA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MNTA, evaluating the profitability, health, valuation and growth aspects
- Momenta Pharma (MNTA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Momenta Pharma (MNTA) Sales and EPS estimates to see what analysts future expectations are.
- Momenta Pharma (MNTA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Momenta Pharma (MNTA) Insider and Institutional Ownership to learn about the owners and their transactions.
- Momenta Pharma (MNTA) Stock Chart to make your own analysis
- Momenta Pharma (MNTA) Latest news and press-releases to stay up to date.
Does Momenta Pharma (MNTA) stock pay dividends?
MNTA does not pay a dividend.
What is the Price/Earnings (PE) ratio of Momenta Pharma (MNTA)?
Momenta Pharma (MNTA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.23).
MNTA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MNTA. When comparing the yearly performance of all stocks, MNTA is one of the better performing stocks in the market, outperforming 98.46% of all stocks.
MNTA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to MNTA. While MNTA has a great health rating, there are worries on its profitability.
MNTA Financial Highlights
Over the last trailing twelve months MNTA reported a non-GAAP Earnings per Share(EPS) of -2.23. The EPS decreased by -4.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -757.62% | ||
| ROA | -43.54% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
MNTA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 69% to MNTA. The Buy consensus is the average rating of analysts ratings from 9 analysts.